tenance treatment, obtained positive results on similar outcomes. 6 7 Moreover, heroin assisted maintenance treatment was found to be cost beneficial in Switzerland 8 and cost effective in the Netherlands compared with methadone maintenance treatment. 9 Since these results were obtained, this treatment option has been extended beyond the trial periods, and heroin has been approved by the regulatory bodies for treating opioid dependence. In all three coun� tries, the intake of medical heroin is supervised and occurs a maximum of three times a day, and patients recover from acute intoxication before leaving the treatment clinic. Notably, heroin has been a treatment option for heroin misusers in the United Kingdom for several decades, albeit on a relatively small scale and under different conditionswith lower aver� age dosing and less supervised intake. 10
Use of maintenance
The above summary makes the recent use of heroin assisted maintenance treatment look like a straightforward scientific success story, and not like a topic for debate in the BMJ. However, since the original heroin assisted maintenance treatment programme was proposed in Switzerland in the early 1990s, there has been scientific, and perhaps more importantly, larger public debate on the eth� ics, safety, and clinical value of prescribing heroin, and to a lesser degree, on maintenance treatment in general. Overall, maintenance with buprenorphine and, to a larger degree, methadone is more successful than treatment focusing on abstinence or using placebos. 11 Given the nature of opioid dependence as a chronic relapsing disease, 12 these results are not surprising. Opioid maintenance treatment generally seems to be well justified for treating this disease. And if maintenance is if maintenance is generally justifiable as a form of treatment, why why should heroin not be used as one such phar� be used as one such phar� such phar� phar� macological agent?� One reason that has been One reason that has been cited is safety, both for the patient 13 and for the general public (for example, through diversion or the risk of trivialising the dangers of heroin, leading to an increase in use). Results from the Swiss studies, however, show that mortal� ity among patients in heroin assisted mainte� nance programmes is low, and lower than for patients in other maintenance programmes. 14 In addition, the wider safety concerns could not be empirically confirmed in Switzerland or the Netherlands. 15 Finally, the incidence of heroin dependence has decreased greatly in Switzerland since the start of the trials, and cur� rently heroin has a more negative image than it did 15 years ago. 16 Overall, we see no convincing reason why heroin assisted maintenance treatment should not be part of a comprehensive treatment sys� tem for opioid dependence. However, the development of an overall integrated treat� ment system is crucial. All studies to date have been conducted in samples of refractory addicts with severely compromised health and several previous failed attempts of methadone maintenance treatment. Our current knowl� edge about the effectiveness of heroin assisted maintenance treatment is restricted to these groups and to the context of countries where there is already an established and effective comprehensive system for treating opioid dependence. Although we currently do not have the necessary empirical evidence for establishing heroin assisted maintenance treat� ment in other circumstances, addition of her� oin assisted maintenance treatment would be likely to improve the overall treatment system, especially with respect to so called treatment resistant and refractory opioid addicts. Recently, a public hearing of a Danish parliament sub� c o m m i t t e e d i s c u s s e d whether heroin assisted maintenance treat� ment should be offered experimentally to reduce health and social harm related to use of heroin (www.tekno.dk/ordineret�heroin). This is just one in a series of similarexisting or proposedprogrammes in Europe, North America, and Australia. 1 We believe that such treatment is appropriate for heroin misusers under certain circumstances.
Supporting evidence
Increasing heroin misuse in the United States in the early 1970s led to a public debate about prescribing heroin as a last resort form of opioid maintenance therapy for people with chronic heroin dependence. In 1973 Lorrin Koran advocated in the New England Journal of Medicine that "carefully designed clinical research on the safety and efficacy of heroin maintenance should be undertaken, particu� larly with addicts not helped in current treat� ments." 2 Some 35 years later, three important research studies have been completed. In Swit� zerland, a small randomised trial 3 and a study using natural cohort designs 4 found heroin assisted maintenance treatment to be feasible and effective for a group of heroin misusers who were refractory to treatment, as charac� terised by long term heroin dependence; physical, psy� chological, or social deficits; and unsuccessful previous treatment. 4 5 Effectiveness was observed in treatment retention; somatic health outcomes such as epileptic episodes, abscesses, or cachexia; mental health out� comes such as affective or anxiety disorders; heroin and cocaine misuse; and criminal out� comes such as property offences or drug traf� ficking (on the basis of self report and objective measures). 5 Large randomised controlled clinical tri� als in the Netherlands and Germany, which compared different modes of heroin assisted maintenance treatment with methadone main� Prescribing heroin to heroin addicts is a strategy beloved by top police officers 1 and succes� sive home secretaries. 2 It is a strategy, though, borne of utter frustration at our seeming inability to tackle an escalating drug problem. If you cannot stop addicts commit� ting crimes to fund their drug habit then, so the argument goes, the next best thing is to provide them with the drugs that are the rea� son they are committing the crimes in the first place. The logic may seem faultless, but at the back of your mind is the nagging question, "Is it treatment or is it social prob� lem prescribing?�"
The evidence in relation to heroin pre� scribing is far from conclusive. On the posi� tive side Nordt and Stohler have suggested that heroin prescribing led to a large reduc� tion in incidence of heroin addiction in Switzerland, although the authors also point out that such prescribing may have reduced individuals' inclinations to cease their her� oin use. 3 A London study found no health benefits associated with heroin prescribing, 4 whereas various Dutch and Swiss heroin trials have identified a range of benefits including improved social functioning and psychological and physical health. 5 6 What addicts with a prescription for the drug that they have become dependent on. And yet the reason they are committing those crimes, and taking such enormous and persistent risks with their health, is because the drugs have become more important than life itselfthat is the nature of drug addiction. And that is the problem that drug treatment services need to tackle.
Research has shown that with the right services in place it is possible to do more than simply stabilise addicts' continued drug use through the prescribing route. For example, the Australian treatment outcome study, which followed up 429 heroin users recruited from a random sample of drug treatment agencies 36 months after starting treatment, found that 40% of drug users had been abstinent for the preceding 12 months and 25% had been abstinent for the preceding 24 months. 10 In a similar Scottish study of 695 addicts, re�interviewed 33 months after they had started treatment for drug misuse, 29.4% of those who had been provided with residential rehabilitation had been abstinent for at least 90 days before being interviewed compared with only 3.4% of those receiving methadone maintenance. 11 All of the residential rehabilitation services included in this study followed an absti� nence based programme.
But do addicts coming forward for treat� ment actually want heroin to be prescribed to them?� A study of over 1033 drug users starting treatment in 2001 asked participants what they wanted to get from the drug treat� ment services they were contacting. 12 Most of those questioned said that they wanted the services to help them become drug free. Health services need to ensure that they are supporting addicts' attempts to become drug free, and they need to be extremely cautious about any extension of a policy that could be seen as a route to maintaining rather than reducing an individual's drug dependency.
Competing interests: None declared. All references are in the version on bmj.com. Some heroin addicts are very difficult to treat. Jürgen Rehm and Benedikt Fischer believe that maintenance with heroin is the way forward for this group, but Neil McKeganey argues that it is treating the effects of misuse not the addiction is often quite difficult to identify from these studies is the degree to which the improved outcomes are the result of the heroin pre� scribed or other elements of the therapeutic programme provided. The cost of treating an addict with heroin is estimated to be three to four times that of treating an addict with methadone. 7
Risks of prescribing
In the face of the additional costs and incon� clusive evidence, many clinicians are wary of prescribing heroin. Their anxieties are understand� able, given the high profile cases of doctors who have prescribed heroin to addicts and then subsequently found themselves facing a General Medical Council inquiry into their prescribing practices. 8 At a clinical level prescribing heroin to her� oin addicts is a risky strategy. Once you start, it is difficult not to feel that you have ceded authority for your prescribing to your patient. What, for example, do you say to patients who threaten to resume their previous life of crime if you reduce their heroin prescription?� What do you say to the cocaine addict who asks why he cannot have cocaine provided in the same way as the heroin addict?� Opening up heroin prescribing to addicts could lead to massive pressure on doctors to prescribe increasing amounts of the drug.
It was in part as a result of that pressure that the Interdepartmental Committee on Drug Addiction advised the UK government in 1965 that only appropriately certified doctors should prescribe heroin to addicts. The com� mittee's decision was influenced by the case of Lady Frankau, a noted London psychiatrist who in 1962 prescribed more than 600 000 heroin tablets to her addict patients. 9
What are we treating? Prescribing heroin to heroin addicts, how� ever, makes sense only if your primary con� cern is to treat not their drug dependency but the consequences of their drug use. You may want to reduce their use of street drugs, the risks to health from HIV or hepatitis C virus, the risks of overdose, or their crimi� nality. With all of these aims in mind you may conclude that it makes sense to provide WHERE DO YOU STAND ON THE ISSUE? tell us on bmj.com at the back of your mind is the nagging question, "Is it treatment or is it social problem prescribing?"
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